Caribou Biosciences, Inc.

Filed a patent for "novel crispr-associated (cas) protein" on Thu, February 6, 2025

Filed a patent for "in vitro validation methods for cd19-targeting cell therapies" on Wed, July 26, 2023

Filed a patent for "in vitro validation methods for cd19-targeting cell therapies" on Wed, July 26, 2023

Filed a patent for "diagnostic and therapeutic methods for use with ror1 antagonists" on Thu, June 29, 2023

Filed a patent for "treatment of autoimmune diseases with bcma-targeting engineered immune cells" on Mon, May 1, 2023

Filed a patent for "treatment of autoimmune diseases with bcma-targeting engineered immune cells" on Fri, September 22, 2023

Filed a patent for "anti-ror1 chimeric antigen receptors (cars), cells expressing the cars and related methods" on Thu, October 24, 2024

Filed a patent for "dna-containing polynucleotides and guides for crispr type v systems, and methods of making and using the same" on Thu, April 13, 2023

Filed a patent for "anti-ror1 antibody and ror1-targeting engineered cells" on Thu, July 18, 2024

Filed a patent for "anti-ror1 chimeric antigen receptors (cars), car-nk cells and related methods" on Fri, December 9, 2022

Filed a patent for "anti-ror1 chimeric antigen receptors (cars), cells expressing the cars and related methods" on Mon, February 6, 2023

Filed a patent for "compositions and methods of nucleic acid-targeting nucleic acids" on Thu, May 23, 2024

Filed a patent for "anti-ror1 antibody and ror1-targeting engineered cells" on Thu, November 30, 2023

Filed a patent for "anti-ror1 chimeric antigen receptors (cars), cells expressing the cars and related methods" on Thu, June 29, 2023

Filed a patent for "modified cascade ribonucleoproteins and uses thereof" on Thu, May 30, 2024

Filed a patent for "humanized bcma antibody and bcma-car-t cells" on Thu, June 6, 2024

Filed a patent for "anti-ror1 chimeric antigen receptors (cars), car-nk cells and related methods" on Fri, September 30, 2022

Filed a patent for "humanized bcma antibody and bcma-car-t cells" on Thu, July 14, 2022

Filed a patent for "therapeutic applications of crispr type v systems" on Wed, April 13, 2022

Filed a patent for "therapeutic applications of crispr type v systems" on Mon, April 18, 2022

Filed a patent for "crispr abasic restricted nucleotides and crispr accuracy via analogs" on Thu, November 3, 2022

Filed a patent for "ror-1 antibody and ror-1-car-t cells" on Tue, May 24, 2022

Filed a patent for "cytokine-receptor fusions for immune cell stimulation" on Thu, May 26, 2022

Filed a patent for "treatment of autoimmune diseases with engineered immune cells" on Mon, June 6, 2022

Filed a patent for "treatment of autoimmune diseases with engineered immune cells" on Fri, October 14, 2022